Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Inovio Pharma (INO)

Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NYSE:PFE),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END

SBFM : 2.99 (+5.65%)
MRNA : 69.86 (-2.96%)
PFE : 29.75 (-0.27%)
INO : 6.77 (-0.15%)
VIR : 7.80 (-1.64%)
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031

SBFM : 2.99 (+5.65%)
MRNA : 69.86 (-2.96%)
PFE : 29.75 (-0.27%)
INO : 6.77 (-0.15%)
VIR : 7.80 (-1.64%)
Inovio Pharmaceuticals (INO) Q2 2024 Earnings Call Transcript

INO earnings call for the period ending June 30, 2024.

INO : 6.77 (-0.15%)
Inovio: Q2 Earnings Snapshot

Inovio: Q2 Earnings Snapshot

INO : 6.77 (-0.15%)
5 Analyst-Approved Stocks Set to Join the Russell Microcap Index

As a part of the annual Russell index rebalancing, here are five stocks set to join the Russell Microcap Index this year, which analysts have tagged with consensus ‘buy’ ratings.

HUT : 11.02 (-3.50%)
^BTCUSD : 62,118.97 (+3.10%)
URG : 1.1800 (+3.51%)
LUNR : 7.47 (+38.33%)
INO : 6.77 (-0.15%)
AISP : 2.56 (-1.54%)
Better Buy: Inovio Pharmaceuticals vs. Novavax

Both biotechs have been struggling for a while, but there might be some hope for them.

PFE : 29.75 (-0.27%)
NVAX : 12.56 (-2.86%)
INO : 6.77 (-0.15%)
Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call Transcript

INO earnings call for the period ending March 31, 2024.

INO : 6.77 (-0.15%)
Inovio: Q1 Earnings Snapshot

Inovio: Q1 Earnings Snapshot

INO : 6.77 (-0.15%)
This Under-the-Radar Stock Is Up by 96% This Year: Time to Buy?

Can the biotech succeed after a string of failures?

INO : 6.77 (-0.15%)
Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript

INO earnings call for the period ending December 31, 2023.

INO : 6.77 (-0.15%)

Barchart Exclusives

3 Top Dividend Stocks to Buy This September
After today's jumbo rate cut from the Fed, here are three dividend stocks to bolster your portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar